CHINA HEALTHCARE:WHAT TO EXPECT FOR ASCO?

时间:2017年04月21日 15:01:46 中财网
ASCO abstract titles were released online earlier this morning
  We summarize key data presentation in Figure 1 on the next page for Chinese companies, while highlighting the following: 1) Anlotinib P3 data in 3L NSCLC;2) Fruquintinib P3 data in 3L CRC; 3) BGB-A317 (PD-1) P1 data; 4)DTRMWXHS-12 (BTK inhibitor from Hisun Pharma) P1 data. According to theASCO website, the abstracts will be released on May 17.
□ .J.a.c.k. .H.u./.L.i.n.c. .Y.i.u  .德.意.志.银.行.股.份.有.限.公.司
各版头条
pop up description layer